Who owns ONKURE THERAPEUTICS INC-A?
- Ticker: OKUR
- CUSIP Number: 68277q105
Tip: Access positions for across all investors
Analyze quarterly positions in Onkure Therapeutics Inc-a with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Onkure Therapeutics Inc-a stock
Who bought or sold ONKURE THERAPEUTICS INC-A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Acorn Capital Advisors | 2.8M | $7.8M | 0% | Sep 2025 |
|
| Citadel Advisors | 1.0M | $2.8M | -7% | Sep 2025 |
|
| Shay Capital | 918k | $2.5M | 17% | Sep 2025 |
|
| Vanguard Group | 678k | $1.9M | -4% | Sep 2025 |
|
| Highbridge Capital Management | 650k | $1.8M | -2% | Sep 2025 |
|
| Vestal Point Capital | 635k | $1.7M | 0% | Sep 2025 |
|
| BlackRock | 565k | $1.6M | 0% | Sep 2025 |
|
| StepStone | 492k | $1.4M | 0% | Sep 2025 |
|
| Cantor Fitzgerald, L. P. | 492k | $1.4M | -27% | Sep 2025 |
|
| NEA Management Company | 479k | $1.3M | 0% | Sep 2025 |
|
| Carlyle | 270k | $742k | 0% | Sep 2025 |
|
| Prosight Management | 268k | $737k | 68% | Sep 2025 |
|
| Renaissance Technologies | 176k | $483k | 43% | Sep 2025 |
|
| Rangeley Capital | 156k | $428k | 420% | Sep 2025 |
|
| Tang Capital Management | 116k | $320k | -31% | Sep 2025 |
|
| Aisling Capital Management | 89k | $244k | 0% | Sep 2025 |
|
| Geode Capital Management | 85k | $234k | 0% | Sep 2025 |
|
| Sphera Funds Management | 61k | $166k | 0% | Sep 2025 |
|
| GSA Capital Partners | 59k | $163k | 172% | Sep 2025 |
|
| Aldebaran Capital | 44k | $121k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 27k | $73k | -1% | Sep 2025 |
|
| Two Sigma Investments | 25k | $70k | -2% | Sep 2025 |
|
| Northern Trust | 23k | $62k | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 20k | $54k | -22% | Sep 2025 |
|
| Morgan Stanley | 17k | $40k | 100% | Jun 2025 |
|
| Wells Fargo & Company | 9.5k | $26k | 25% | Sep 2025 |
|
| China Universal Asset Management | 2.3k | $6.2k | -13% | Sep 2025 |
|
| Tower Research Capital | 1.9k | $5.3k | 6% | Sep 2025 |
|
| Barclays | 621.00 | $1.7k | -38% | Sep 2025 |
|
| Mirae Asset Global Investments | 497.00 | $1.4k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 423.00 | $1.2k | 83% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 364.00 | $1.0k | 9% | Sep 2025 |
|
| Gf Fund Management | 271.00 | $745.006100 | -13% | Sep 2025 |
|
| UBS Group | 205.00 | $563.996000 | 13% | Sep 2025 |
|
| Royal Bank of Canada | 190.00 | $1.0k | -23% | Sep 2025 |
|
| Trust Co Of Toledo Na | 136.00 | $374.000000 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 100.00 | $275.000000 | 0% | Sep 2025 |
|
| Group One Trading | 56.00 | $154.000000 | 0% | Sep 2025 |
|
| FMR | 50.00 | $138.000000 | 100% | Sep 2025 |
|
| MAI Wealth Advisors | 6.00 | $16.999800 | 0% | Sep 2025 |
|
Who sold out of Onkure Therapeutics Inc-a?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Affinity Asset Advisors | Jun 2025 | 348k | $832k |
| Deep Track Capital | Jun 2025 | 181k | $431k |
| Nantahala Capital Management | Jun 2025 | 54k | $130k |
| Landscape Capital Management | Jun 2025 | 41k | $98k |
| Bailard | Jun 2025 | 14k | $34k |
| XTX Topco | Jun 2025 | 11k | $25k |
| ADAR1 Capital Management | Jun 2025 | 10k | $24k |